M. Fojtů, et al.: Silicane Derivative Increases Doxorubicin Efficacy in an Ovarian Carcinoma Mouse Model: Fighting Drug Resistance
Check out the latest publication by Michaela Fojtů et al. describing the effects of the anticancer drug doxorubicin, enhanced by polysiloxane nanocarrier.
We are proud that Telight Q-Phase helped scientists to precisely quantify the changes in cellular motility which may affect tumor invasiveness. But the paper is literally stuffed with much more results proving the expanding potential of nanomaterials for biomedicine applications.